ID – 180
Brand Company – Revance Therapeutics
Date – 01/04/2023
Brand – Revance Therapeutics
Type – Creative
Territory – South Korea
Region – Asia Pacific/ APAC
Category – Pharma & Healthcare
Current Agency – Grey Group
Current Agency Description – Grey Group
Incumbent Agency –
Incumbent Agency Description –
Status – Awarded
Est Billing – USD$3,000,000